Me ya kamata in san game da shi?
Ana amfani da kariyar C vitamin a matsayin kare ta jiki akan wasu yanayi na kiwon lafiya, irin su sanyi na kowa . Amma yayin da bincike ya nuna cewa yalwaccen bitamin C a cikin abincinka na iya karewa daga wasu matsalolin lafiya, akwai rashin shaidar kimiyya don taimakawa wajen amfani da bitamin C.
Yana amfani da Vitamin C Ƙari
An samo ta a cikin yawancin 'ya'yan itatuwa da kayan marmari, bitamin C ya zama dole don samuwa ta collagen, warkar da rauni, da kuma gyaran gyare-gyare, ƙashi, da hakora.
A madadin maganin, cibiyoyin bitamin C suna bayar da amfanon antioxidant kuma an ɗauka don taimakawa cikin yanayin kiwon lafiya:
- sanyi
- fuka
- mashako
- cututtukan zuciya na zuciya
- cataracts
- glaucoma
- hawan jini
- Kwayar Parkinson
Wasu masu gabatarwa sunyi iƙirarin cewa maye gurbin bitamin C zai iya inganta rigakafi, kazalika da taimakawa wajen rigakafin ciwon daji.
Amfanin Lafiya na Ingancin Camin C:
A yau, karatun kan abubuwan kiwon lafiya na abubuwan bitamin C sun haifar da sakamako mai ma'ana. A nan ne kalli wasu bayanai masu mahimmanci:
1) Colds
A cikin binciken 2007 game da gwaje-gwajen gwaji 30 (ya ƙunshi mutane 11,350), masu bincike sun kammala cewa abubuwan da suka hada da bitamin C ba su taimaka wajen yaki da sanyi ba a yawancin jama'a. Duk da haka, mawallafin mawallafin sun lura cewa kariyar bitamin C zai iya zama wani amfani ga mutane da ke zaune a yanayin sanyi ko kuma wadanda aka fice a wasu lokutan lokaci na motsa jiki mai tsanani (irin su marathon gudu).
Ƙari: 11 Ma'aikata na Kwayoyi na Colds | Yadda za a bunkasa tsarin ku marar lafiya
2) Cutar zuciya
Yin amfani da karin bitamin C ba zai rage hadarin manyan cututtuka na zuciya ba, bisa ga binciken 2008 na likitoci 14,641 maza (shekaru 50 da haihuwa a farkon binciken). Don kimanin shekaru takwas, masu karatu sun dauki kobo ko gurasar Camin C 500 na kowace rana.
(Bugu da ƙari, ƙungiyar ta ci gaba da daukar nauyin IU na bitamin E kowace rana.) Sakamakon binciken ya nuna cewa babu wani bitamin E ko kuma karin bitamin C da ke da babbar tasiri akan manyan cututtuka na zuciya, irin su ciwon bugun jini da ciwon zuciya.
Duba Har ila yau: Yoga, Garlic, da kuma 15 Sauran hanyoyin da za a rage dan jini Hanyoyin Halitta na Rigakafin Rigakarewa | 6 Magungunan Kwayoyi na Kwayoyin Cutar Kwayar cututtuka
3) Ciwon daji
Don nazarin da aka buga a shekara ta 2009, 'yan mata 8,171 sun dauki kobo ko gurasar Camin C 500 a kowace rana (da kuma bitamin E da beta kowace rana) don kimanin shekaru 9.4. Sakamakon binciken ya nuna cewa kariya tare da bitamin C, bitamin E, ko beta carotene bai taimaka wajen hana ciwon daji ba.
Bugu da ƙari kuma, binciken da aka yi a shekara ta 2008 da mutane 77,721 maza da mata (shekarun shekaru 50 zuwa 76) sun gano cewa amfani da bitamin C da dogon lokaci ba ta rage yawan cutar ciwon huhu ba. Kuma a cikin 2004 nazari na binciken 14 game da maganin antioxidant da kuma rigakafin cututtuka na gastrointestinal - ciki har da hudu gwaje-gwajen da suka shafi bitamin C - masu bincike basu sami tabbacin cewa maye gurbin antioxidant ya hana ciwon daji na gastrointestinal.
Ƙari: Za a iya Resveratrol Ku Cike Kankara-Free? | Turmeric don Cancer Defence?
Caveats
Ko da yake ana amfani da bitamin C lafiya, manyan asosai na iya haifar da mummunan illa, ciki har da duwatsu na koda, cututtuka mai tsanani, da kuma tashin hankali. Mene ne ƙari, nazarin shekarar 2008 ya nuna cewa shan kariyar bitamin C a yayin da ake jiyyar cutar cancer zai iya rage tasirin wasu kwayoyi masu cutar chemotherapy .
Ba a gwada wajibi don kare lafiyayyu ba kuma saboda abin da ake amfani da abincin abincin ya zama abin ƙyama, ƙididdigar wasu samfurori na iya bambanta da abin da aka ƙayyade akan lakabin samfurin. Har ila yau, ka tuna cewa kare lafiyar abin da ke cikin mata masu juna biyu, iyaye mata, yara, da waɗanda ke da yanayin kiwon lafiya ko masu shan magunguna ba a kafa su ba.
Zaka iya samun ƙarin bayani game da amfani da kari a nan .
Yin amfani da Vitamin C don Lafiya
Saboda rashin goyon bayan kimiyya don amfanin lafiyar lafiyar bitamin C, yana da mahimmanci kada ku dogara da bitamin C samfurori a matsayin mahimmin maganin kowane yanayin lafiya. Don samun isasshen bitamin C a kowace rana, duba farko ga kayan abinci kamar citrus, strawberries, tumatir, barkono, ganye mai laushi, da cantaloupe.
Idan kana neman magancewa ko hana wani yanayin tare da kariyar bitamin C - ko kowane nau'i na abincin abincin - ka tabbata ka tuntuɓi likitanka kafin ka fara tsarin kariyarka. Ka tuna cewa kada a yi amfani da maganin rigakafin maye gurbin kulawa na musamman. Yin magance yanayin da kai tsaye da kaucewa ko jinkirta kulawa na gari yana iya zama mummunan sakamako.
Sources:
Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. "Abubuwa masu cike da antioxidant don hana cututtukan gastrointestinal." Cochrane Database Syst Rev 2004 18; (4): CD004183.
Douglas RM, Hemilä H, Chalker E, Treacy B. "Vitamin C don karewa da kuma magance yanayin sanyi." Cochrane Database Syst Rev. 2007 18; (3): CD000980.
Heaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, O'Connor OA. "Vitamin C ta tayar da kwayoyi masu amfani da kwayoyin maganin antineoplastic." Cancer Res. 2008 1; 68 (19): 8031-8.
Lin J, Cook NR, Albert C, Zaharris E, Gaziano JM, Van Denburgh M, Bure JE, Manson JE. "Vitamin C da E da kuma beta carotene supplementation da kuma ciwon daji: gwajin gwagwarmaya bazuwa." J Natl Cancer Inst. 2009 7; 101 (1): 14-23.
Memorial Sloan-Kettering Cancer Center. Game da ganye: Vitamin C. Fabrairu 2009.
Cibiyoyin Lafiya na Ƙasar. "Vitamin C (ascorbic acid): MedlinePlus Medical Encyclopedia". Maris 2010.
Cibiyoyin Lafiya na Ƙasar. "Vitamin C (ascorbic acid): MedlinePlus Ƙari". Agusta 2009.
Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, Gaziano JM. "Vitamin E da C a cikin rigakafin cututtuka na zuciya da jijiyoyin jini a cikin maza. JAMA. 2008 12; 300 (18): 2123-33.
Slatore CG, Littman AJ, Au DH, Satia JA, White E. "Yin amfani da ƙananan mahadamins, bitamin C, bitamin E, da folate na tsawon lokaci ba su rage hadarin ciwon huhu ba." Am J Reshir Crit Care Med. 2008 1; 177 (5): 524-30.